• BI-505 chembl:CHEMBL2109482 Antineoplastic

    Alternate Names:

    BI-505

    Drug Info:

    FDA Approval not approved
    Drug Class antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 18.55

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name BI-505
    Novel drug target Established target
    Direct Interaction yes

    PMIDs:
    None found


  • Interaction Score: 1.24

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD